Evidence map›Paper›PMID 42878653›Full record

ArticleThe Cochrane database of systematic reviews2026

Letter to the editor: Amyloid-beta-targeting monoclonal antibodies for people with mild cognitive impairment or mild dementia due to Alzheimer's disease.

Donatienne Van Weehaeghe, Andrea Varrone, Matthias Brendel, Lisbeth Marner, Antoine Verger, Nelleke Tolboom, Igor Yakushev, Francesco Fraioli, Pablo Aguiar Fernandez, Valentina Berti and 3 more

Abstract readEditorial
In one paragraph

Article in The Cochrane database of systematic reviews, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Donatienne Van WeehaegheDepartment of Radiology and Nuclear Medicine, Ghent University Hospital, 9000, Ghent, Belgium.
Andrea VarroneDepartment of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet & Stockholm health care services, 171 77, Stockholm, Sweden.
Matthias BrendelDepartment of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
Lisbeth MarnerDepartment of Nuclear Medicine, Copenhagen University Hospital Herlev and Gentofte, Copenhagen, Denmark.
Antoine VergerDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, IADI, INSERM U1254, Université de Lorraine, Nancy, France.
Nelleke TolboomDepartment of Radiology and Nuclear Medicine, University Medical Centre Utrecht, Utrecht, The Netherlands.
Igor YakushevDepartment of Nuclear Medicine, School of Medicine, TUM University Hospital, Technical University of Munich, Munich, Germany.
Francesco FraioliInstitute of Nuclear Medicine, University College London, London, United Kingdom.
Pablo Aguiar FernandezCIMUS, Universidade Santiago de Compostela & Nuclear Medicine Department, University Hospital IDIS, Santiago de Compostela, Spain.
Valentina BertiNuclear Medicine Unit, Department of Experimental and Clinical Biomedical Sciences, University of Florence, Italy.
Roland WiestInstitute of Diagnostic and Interventional Neuroradiology, Inselspital, Bern University Hospital, Bern, Switzerland.
Federica AgostaCenter for Alzheimer's disease and related disorders (CARD), Unit of Neurology, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.
Massimo FilippiCenter for Alzheimer's disease and related disorders (CARD), Unit of Neurology, IRCCS Ospedale San Raffaele and Vita-Salute San Raffaele University, Milan, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Evidence synthesis

Identifiers

PMID42878653
PMCPMC13671171

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.